HR Execs on the Move

ValGenesis

www.valgenesis.com

 
As a pioneer in the development of automated validation software solutions, ValGenesis leads the way with a unique paperless validation process that tracks the validation status of any GxP system in real time. With years of development and refinement in place, ValGenesis is the first to offer users real-time paperless validation via electronic execution thereby minimizing ineffectiveness and maximizing efficiency. ValGenesis automates and manages the validation life cycle and provides real time validation status of any system corporate wide.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.valgenesis.com
  • 395 Oyster Point Boulevard Suite 228
    South San Francisco, CA USA 94080
  • Phone: 510.445.0505

Executives

Name Title Contact Details
Siva Samy
 CEO & Chief Product Strategist Profile
Steve Reynolds
 Chief Revenue Officer Profile
Kevin O'Donnell
 Chief Financial Officer Profile

Similar Companies

Evelo Therapeutics

Evelo Therapeutics is the latest breakthrough microbiome company from Flagship VentureLabs, the innovation foundry of Flagship Ventures.

Poseida

Poseida Therapeutics is a clinical-stage biotechnology company translating best-in-class technology into lifesaving cell and gene therapies for patients with high unmet medical need. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as in vivo gene therapies for orphan genetic diseases. These cell therapies and the gene therapies soon to come are products of our proprietary suite of industry-leading gene engineering technologies, including the piggyBac® DNA Modification System, Cas-CLOVER™ and TAL-CLOVER™ site-specific nucleases.

Michael

Michael is a Franklinton, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allcells LLC

Allcells LLC is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

CuraSen Therapeutics

CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases, including Parkinson`s Disease, Alzheimer`s Disease and less common neurodegenerative disorders.